EP3247808

FRED HUTCHINSON CANCER RESEARCH CENTER
Application Number
EP16740786A
Filing Date
Jan 21, 2016
Status
Revoked
Jan 26, 2024
Grant Date
May 5, 2021
External Links
Slate, Register

Biblio Summary

The patent EP3247808B1 was granted on May 5, 2021 by Fred Hutchinson Cancer Research Center The patent is currently Revoked.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMAN LIMITEDFeb 3, 2022ADMISSIBLE
MILTENYI BIOTEC B.V. & CO. KGFeb 1, 2022ADMISSIBLE

The table below shows the patents of Fred Hutchinson Cancer Research Center that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3688157High Efficiency Targeted In Situ Genome-Wide ProfilingApr 27, 20221
EP3636778Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)Jan 12, 20222
EP3363901Compositions And Methods For Accurately Identifying MutationsDec 30, 20203